Literature DB >> 29892917

Congenital Myasthenic Syndromes in 2018.

Andrew G Engel1.   

Abstract

PURPOSE OF REVIEW: Summarize features of the currently recognized congenital myasthenic syndromes (CMS) with emphasis on novel findings identified in the past 6 years. RECENT
FINDINGS: Since the last review of the CMS in this journal in 2012, several novel CMS were identified. The identified disease proteins are SNAP25B, synaptotagmin 2, Munc13-1, synaptobrevin-1, GFPT1, DPAGT1, ALG2, ALG14, Agrin, GMPPB, LRP4, myosin 9A, collagen 13A1, the mitochondrial citrate carrier, PREPL, LAMA5, the vesicular ACh transporter, and the high-affinity presynaptic choline transporter. Exome sequencing has provided a powerful tool for identifying novel CMS. Identifying the disease genes is essential for determining optimal therapy. The landscape of the CMS is still unfolding.

Entities:  

Keywords:  Congenital myasthenic syndromes; EMG; Expression studies; Mutation analysis; Neuromuscular junction

Mesh:

Year:  2018        PMID: 29892917     DOI: 10.1007/s11910-018-0852-4

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  80 in total

1.  Acetylcholine receptor M3 domain: stereochemical and volume contributions to channel gating.

Authors:  H L Wang; M Milone; K Ohno; X M Shen; A Tsujino; A P Batocchi; P Tonali; J Brengman; A G Engel; S M Sine
Journal:  Nat Neurosci       Date:  1999-03       Impact factor: 24.884

2.  Beneficial effects of albuterol in congenital endplate acetylcholinesterase deficiency and Dok-7 myasthenia.

Authors:  Teerin Liewluck; Duygu Selcen; Andrew G Engel
Journal:  Muscle Nerve       Date:  2011-09-23       Impact factor: 3.217

3.  Refinement of the clinical phenotype in musk-related congenital myasthenic syndromes.

Authors:  V Mihaylova; M A M Salih; M M Mukhtar; H A Abuzeid; S M El-Sadig; M von der Hagen; A Huebner; G Nürnberg; A Abicht; J S Müller; H Lochmüller; V Guergueltcheva
Journal:  Neurology       Date:  2009-12-01       Impact factor: 9.910

4.  Congenital myasthenic syndrome associated with paucity of synaptic vesicles and reduced quantal release.

Authors:  T J Walls; A G Engel; A S Nagel; C M Harper; V F Trastek
Journal:  Ann N Y Acad Sci       Date:  1993-06-21       Impact factor: 5.691

5.  A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel.

Authors:  A G Engel; E H Lambert; D M Mulder; C F Torres; K Sahashi; T E Bertorini; J N Whitaker
Journal:  Ann Neurol       Date:  1982-06       Impact factor: 10.422

6.  Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor epsilon subunit.

Authors:  K Ohno; H L Wang; M Milone; N Bren; J M Brengman; S Nakano; P Quiram; J N Pruitt; S M Sine; A G Engel
Journal:  Neuron       Date:  1996-07       Impact factor: 17.173

7.  MUSK, a new target for mutations causing congenital myasthenic syndrome.

Authors:  Frédéric Chevessier; Brice Faraut; Aymeric Ravel-Chapuis; Pascale Richard; Karen Gaudon; Stéphanie Bauché; Cassandra Prioleau; Ruth Herbst; Evelyne Goillot; Christine Ioos; Jean-Philippe Azulay; Shahram Attarian; Jean-Paul Leroy; Emmanuel Fournier; Claire Legay; Laurent Schaeffer; Jeanine Koenig; Michel Fardeau; Bruno Eymard; Jean Pouget; Daniel Hantaï
Journal:  Hum Mol Genet       Date:  2004-10-20       Impact factor: 6.150

8.  Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes.

Authors:  Violeta Mihaylova; Juliane S Müller; Juan J Vilchez; Mustafa A Salih; Mohammad M Kabiraj; Adele D'Amico; Enrico Bertini; Joachim Wölfle; Felix Schreiner; Gerhard Kurlemann; Vedrana Milic Rasic; Dana Siskova; Jaume Colomer; Agnes Herczegfalvi; Katarina Fabriciova; Bernhard Weschke; Rosana Scola; Friederike Hoellen; Ulrike Schara; Angela Abicht; Hanns Lochmüller
Journal:  Brain       Date:  2008-01-07       Impact factor: 13.501

9.  Pre- and post-synaptic abnormalities associated with impaired neuromuscular transmission in a group of patients with 'limb-girdle myasthenia'.

Authors:  C R Slater; P R W Fawcett; T J Walls; P R Lyons; S J Bailey; D Beeson; C Young; D Gardner-Medwin
Journal:  Brain       Date:  2006-08       Impact factor: 13.501

10.  Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII α1 Chain.

Authors:  Clare V Logan; Judith Cossins; Pedro M Rodríguez Cruz; David A Parry; Susan Maxwell; Pilar Martínez-Martínez; Joey Riepsaame; Zakia A Abdelhamed; Alice V R Lake; Maria Moran; Stephanie Robb; Gabriel Chow; Caroline Sewry; Philip M Hopkins; Eamonn Sheridan; Sandeep Jayawant; Jacqueline Palace; Colin A Johnson; David Beeson
Journal:  Am J Hum Genet       Date:  2015-11-25       Impact factor: 11.025

View more
  20 in total

1.  Isolated vocal cord paralysis in two siblings with compound heterozygous variants in MUSK: Expanding the phenotypic spectrum.

Authors:  Chaya Murali; Dong Li; Katheryn Grand; Hakon Hakonarson; Elizabeth Bhoj
Journal:  Am J Med Genet A       Date:  2019-02-04       Impact factor: 2.802

2.  Novel compound heterozygous variants in the GFPT1 gene leading to rare limb-girdle congenital myasthenic syndrome with rimmed vacuoles.

Authors:  Yanyan Ma; Ting Xiong; Guohua Lei; Jiaqi Ding; Rui Yang; Zunbo Li; Jun Guo; Dingguo Shen
Journal:  Neurol Sci       Date:  2021-01-13       Impact factor: 3.307

3.  Clinicopathological-genetic features of congenital myasthenic syndrome from a Chinese neuromuscular centre.

Authors:  Kun Huang; Hui-Qian Duan; Qiu-Xiang Li; Yue-Bei Luo; Fang-Fang Bi; Huan Yang
Journal:  J Cell Mol Med       Date:  2022-06-06       Impact factor: 5.295

Review 4.  Muscle-Specific Kinase Myasthenia Gravis.

Authors:  Lucia S Borges; David P Richman
Journal:  Front Immunol       Date:  2020-05-08       Impact factor: 7.561

5.  Motor Endplate-Anatomical, Functional, and Molecular Concepts in the Historical Perspective.

Authors:  Rüdiger Rudolf; Muzamil Majid Khan; Veit Witzemann
Journal:  Cells       Date:  2019-04-27       Impact factor: 6.600

6.  Congenital myasthenic syndromes.

Authors:  Josef Finsterer
Journal:  Orphanet J Rare Dis       Date:  2019-02-26       Impact factor: 4.123

Review 7.  The congenital myasthenic syndromes: expanding genetic and phenotypic spectrums and refining treatment strategies.

Authors:  An E Vanhaesebrouck; David Beeson
Journal:  Curr Opin Neurol       Date:  2019-10       Impact factor: 5.710

8.  First maternal uniparental disomy for chromosome 2 with PREPL novel frameshift mutation of congenital myasthenic syndrome 22 in an infant.

Authors:  Ping Zhang; Bingbing Wu; Yulan Lu; Qi Ni; Renchao Liu; Wenhao Zhou; Huijun Wang
Journal:  Mol Genet Genomic Med       Date:  2020-01-27       Impact factor: 2.183

9.  Biallelic loss of function variants in SYT2 cause a treatable congenital onset presynaptic myasthenic syndrome.

Authors:  Sandra Donkervoort; Payam Mohassel; Lucia Laugwitz; Maha S Zaki; Erik-Jan Kamsteeg; Reza Maroofian; Katherine R Chao; Corien C Verschuuren-Bemelmans; Veronka Horber; Annemarie J M Fock; Riley M McCarty; Minal S Jain; Victoria Biancavilla; Grace McMacken; Matthew Nalls; Nicol C Voermans; Hasnaa M Elbendary; Molly Snyder; Chunyu Cai; Tanya J Lehky; Valentina Stanley; Susan T Iannaccone; A Reghan Foley; Hanns Lochmüller; Joseph Gleeson; Henry Houlden; Tobias B Haack; Rita Horvath; Carsten G Bönnemann
Journal:  Am J Med Genet A       Date:  2020-08-10       Impact factor: 2.578

10.  Congenital myasthenic syndrome caused by a frameshift insertion mutation in GFPT1.

Authors:  Szabolcs Szelinger; Jonida Krate; Keri Ramsey; Samuel P Strom; Perry B Shieh; Hane Lee; Newell Belnap; Chris Balak; Ashley L Siniard; Megan Russell; Ryan Richholt; Matt De Both; Ana M Claasen; Isabelle Schrauwen; Stanley F Nelson; Matthew J Huentelman; David W Craig; Samuel P Yang; Steven A Moore; Kumaraswamy Sivakumar; Vinodh Narayanan; Sampathkumar Rangasamy
Journal:  Neurol Genet       Date:  2020-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.